-
Our Own WordsPeople with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
-
A Researcher Attends a Conference, This Time as a Patient AdvocateMy most meaningful moments at my first cancer research conference came from embracing my experience as a patient—not as a researcher.
by Jamie Aten
-
Advocacy Spotlight: A Mission to Bring AwarenessMinister and thyroid cancer survivor Thurselle C. Williams speaks at conferences and events about cancer awareness and, ultimately, healing following her 2016 diagnosis.
by Erin L. Boyle
-
Helping Cancer Survivors SleepA clinical trial comparing acupuncture and cognitive behavioral therapy found that they are both helpful for people who are experiencing sleep problems after cancer treatment.
by Cheryl Platzman Weinstock
-
Get Involved
Patient NavigatorsPatient navigators can help cancer patients tackle the trickier points of accessing health care.
by Carisa D. Brewster
-
Survivor Profile
Still in the GameESPN reporter Holly Rowe worked through melanoma treatment.
by Lindsey Konkel
-
Policy Matters
NIH-AACR Conference Examines Immunotherapy RisksThe meeting underscored the importance of NIH funding for cancer research.
by Elizabeth KS Barksdale, PhD
-
So You Want to Serve on a Scientific Review Panel?Cancer patient advocates who review research proposals can provide valuable perspective.
by Bob Riter, Monica Vakiner and Carole Baas
-
New Rule Would Require Breast Density DisclosureA proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
-
The Crowded Field of Checkpoint InhibitorsDrug developers behind currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
by Kate Yandell
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
